2 min read
EMDR for Fear of Cancer Recurrence: When the Ongoing Distress Is About What Might Happen Next
In this article, we explore a more specific psycho-oncology use of EMDR: fear of cancer recurrence, where the central problem is often not a past event alone but the ongoing expectation that threat may return.
Cancer-related distress is not always limited to the moment of diagnosis or treatment. For many patients, the most persistent difficulty is fear of recurrence: the ongoing apprehension that symptoms may return, scans may reveal bad news, or life remains organised around a future threat that has never fully gone away. This makes fear of recurrence a useful and non-generic topic, because the clinical problem is not simply “stress after cancer” but a continuing cycle of monitoring, anxiety, and anticipatory threat. A 2025 study specifically examined EMDR for clinical fear of cancer recurrence, while a 2026 study protocol is also investigating EMDR R-TEP as an early intervention for breast cancer patients.
This is where EMDR becomes clinically interesting. The treatment model is usually associated with memories of past trauma, but in cancer-related distress the relevant targets may include diagnosis scenes, treatment experiences, procedural memories, moments of perceived danger, and present-day triggers such as bodily sensations, anniversaries, or medical follow-up appointments. In practice, that means the therapy may need to work with both past memories and the ongoing anticipatory response attached to future threat. More broadly, psycho-oncology literature continues to recognise cancer as a potentially traumatic experience associated with clinically significant mental health effects in some patients.
It is important not to overstate the evidence. The cancer-specific EMDR literature is still relatively limited compared with the PTSD evidence base, and the presence of early studies or protocols is not the same as settled guidance. But the topic is clinically useful because it points to a real subgroup of patients whose distress is structured around recurrence fear rather than only low mood or general anxiety. That narrower framing is often more accurate and more helpful than writing about “cancer stress” in broad terms.
So EMDR in this context is best understood as a targeted intervention for threat that remains active after treatment has ended. The goal is not to create false reassurance. It is to reduce the degree to which the person remains organised around constant expectation of bad news.
